Dr. Mark J. Goldstein, MD

Dr. Goldstein practices at Connecticut Skinhealth in Shelton, Connecticut.

Dr. Goldstein's NPI, 1902947484, was assigned on February 9, 2007. Dr. Goldstein graduated from New York Medical College in 1981. Dr. Goldstein holds Connecticut license 025369.

Dr. Goldstein's primary practice is Connecticut Skinhealth, at 4 Corporate Dr, Shelton, CT 06484 in Greater Bridgeport County. The practice phone is (203) 538-5685.

Dr. Goldstein's primary practice is Connecticut Skinhealth in Shelton, Connecticut. The medical group on file is Dermatology Physicians of Connecticut. Dmand AI also links Dr. Goldstein to 1 more physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Goldstein practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Goldstein's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Goldstein is licensed in Connecticut.

CMS data shows 1,317 Medicare services from Dr. Goldstein across 9 procedure codes in 2024, for 335 Medicare patients. Medicare paid $52,763 for them. Every service was in an office.

CMS counts 335 Medicare patients who saw Dr. Goldstein in 2024. The largest group is 65 to 74, with 170 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Goldstein's median patient age at 66, with 46% women.

In 2024, Dr. Goldstein wrote 1,029 Medicare Part D claims for 429 patients. 96% of them were for generic drugs. CMS names the drug for 948 of them, across 17 drugs with 11 or more claims each, at $14,320 in total drug cost. In 2023, CMS named 772 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Goldstein for performance year 2024, reported as part of a group. Dr. Goldstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 218 procedures of removal of skin lesions by Dr. Goldstein, more than 80% of the clinicians it reports for that procedure.

Dmand AI links Dr. Goldstein to 3 clinical trials. Conditions studied include Alzheimer Disease, Crohn Disease and Delirium. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Dr. Goldstein that name 3 trials.

CMS Open Payments shows 233 general payments to Dr. Goldstein from 15 drug and device companies from 2016 to 2022. Speaker and faculty fees make up the largest share, 71% of the total. Galderma Laboratories, L.P. paid the most, $69,813. It also lists 4 research payments totaling $6,656 from 2016 to 2018, naming 3 clinical trials.

Dr. Goldstein graduated from New York Medical College in 1981.